Estradiol topical Alternatives Compared
Estradiol topical | Gemtesa (vibegron) | Botox (onabotulinumtoxinA) |
|
---|
Estradiol topical | Gemtesa (vibegron) | Botox (onabotulinumtoxinA) |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Atrophic Vaginitis, Atrophic Urethritis, Overactive Bladder, Dyspareunia. Estradiol topical may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Overactive Bladder. Gemtesa may also be used for purposes not listed in this medication guide. |
Prescription only
Botox is approved to treat many conditions, such as chronic migraine, involuntary muscle contractions or twitching, excessive sweating, increased saliva, and overactive bladder to name a few. Botox... View more |
Related suggestions Overactive Bladder
|
|||||||||||||||||||||||
More about Estradiol topical | More about Gemtesa (vibegron) | More about Botox (onabotulinumtoxinA) | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Estradiol topical has an average rating of 5.1 out of 10 from a total of 491 ratings on Drugs.com. 37% of reviewers reported a positive effect, while 45% reported a negative effect. |
Gemtesa has an average rating of 7.7 out of 10 from a total of 207 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 12% reported a negative effect. |
Botox has an average rating of 5.7 out of 10 from a total of 481 ratings on Drugs.com. 47% of reviewers reported a positive effect, while 41% reported a negative effect. |
||||||||||||||||||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||||||||||
View all Estradiol topical side effects |
View all Gemtesa side effects |
View all Botox side effects |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
Lower cost generic |
N/A |
|||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Estradiol topical prices |
View all Gemtesa prices |
View all Botox prices |
||||||||||||||||||||||||
Dosage Forms | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
Estrace Vaginal Cream, Estring, Imvexxy, Vagifem, Yuvafem |
N/A |
Other onabotulinumtoxinA brands include: Botox Cosmetic | ||||||||||||||||||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||||||||||
N/A |
94 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 260 drugs are known to interact with Estradiol topical:
|
A total of 148 drugs are known to interact with Gemtesa:
|
A total of 120 drugs are known to interact with Botox:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
January 31, 1984 |
December 23, 2020 |
December 09, 1991 |
||||||||||||||||||||||||
WADA Class View classifications | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient Resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.